Favorable government regulations and
increasing outsourcing of pharmaceutical production to the APAC region
is now driving the growth of chiral technology
markets. The global market of chiral technology
which was $4.75 billion in 2010 is projected to grow to
$5.83 billion.
Pharmaceutical
companies have been facing immense pressure on regulatory, pricing and
market fronts and one of the key strategic pursuits they have been focusing
on is identification, evaluation and leveraging the power of chiral technologies
and enabling tools.
New
advances in combinatorial and biocatalysis; asymmetric technologies; chiral
separation technologies; design of chiral kit box complemented by adjacent
technologies like genomics, gene shuffling technologies etc., have opened
up new vistas for the industry to explore. Advances in molecular biology
mean that drug discovery no longer relies on serendipity and drug design
is now a clearly defined process.
Chiral India 2018,
“The business of chirality: Contemporary
and complementary technologies” will highlight the
latest advances in chiral drug development and also explore many dimensions
of contemporary chiral systems and complementary technologies for new
drug design and development. In an attempt to highlight the power of chirality
it will also highlight how chiral chemistry and tools are shaping new
crop protection actives and advanced materials.
Chiral
India 2018 will deliberate on the following strands:
|
Biocatalytic tool box for chiral synthesis
|
Flow chemistry for optimisation of chiral
drug synthesis
|
Novel chiral separation technologies
|
Innovative asymmetric synthesis
|
Overview of chiral manufacturing technologies
|
Combinatorial catalysis in high-throughput
screening
|
New approaches to chiral drug design
(synthetic and biological)
|
|
|